Gilead Sciences Inc

GILD 
(NASDAQ) 
 
$ 66.36 <%= Resources.Global.txtDown %>
Updated 13/06/2019
Change % -0.94% Stock price decreasing
Change -0.63 Stock price decreasing
Volume 4,057,496
High $ 66.98
Low $ 66.20
Open $ 66.91
ISIN
Prev close $ 66.99
# of shares 1,274.90M
Market cap 84,602M USD
Intraday

Market closed
Gilead Sciences Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  66.36 1.5% Stock price increasing 0.9% Stock price increasing 1.1% Stock price increasing 1.2% Stock price increasing -5.5% Stock price decreasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 82.22 1.8% Stock price increasing 7.3% Stock price increasing 3.0% Stock price increasing 16.2% Stock price increasing 30.7% Stock price increasing 13.7% Stock price increasing
 
Bristol-Myers Squibb Company 47.56 1.7% Stock price increasing 0.9% Stock price increasing -4.8% Stock price decreasing -8.7% Stock price decreasing -13.2% Stock price decreasing -8.5% Stock price decreasing
 
Merck & Company Inc (new) 82.78 0.4% Stock price increasing 4.6% Stock price increasing 1.5% Stock price increasing 8.2% Stock price increasing 33.5% Stock price increasing 8.3% Stock price increasing
 
Pfizer Inc 42.76 -0.4% Stock price decreasing 2.7% Stock price increasing 2.3% Stock price increasing -2.4% Stock price decreasing 17.6% Stock price increasing -2.0% Stock price decreasing
 
Amgen Inc 176.08 0.3% Stock price increasing 3.6% Stock price increasing -7.9% Stock price decreasing -8.3% Stock price decreasing -4.8% Stock price decreasing -9.5% Stock price decreasing
 
Celgene Corporation 96.51 0.5% Stock price increasing 1.0% Stock price increasing 9.1% Stock price increasing 41.5% Stock price increasing 23.6% Stock price increasing 50.6% Stock price increasing
 
Novartis NAM SF 0,50 79.74 2.1% Stock price increasing 7.5% Stock price increasing -3.3% Stock price decreasing 2.8% Stock price increasing 22.1% Stock price increasing 7.2% Stock price increasing
 
Roche Hldg AG GEN 246.95 2.1% Stock price increasing 5.7% Stock price increasing 3.0% Stock price increasing 11.5% Stock price increasing 37.3% Stock price increasing 14.6% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,584.40 1.2% Stock price increasing 2.2% Stock price increasing 5.5% Stock price increasing 7.1% Stock price increasing 1.8% Stock price increasing 6.3% Stock price increasing
 
Sanofi 75.98 -3.0% Stock price decreasing 1.3% Stock price increasing -4.5% Stock price decreasing -2.9% Stock price decreasing 10.6% Stock price increasing 0.4% Stock price increasing
 
Biogen Inc 227.67 0.2% Stock price increasing -1.4% Stock price decreasing -31.0% Stock price decreasing -27.6% Stock price decreasing -25.4% Stock price decreasing -24.3% Stock price decreasing

Company profile

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.

Peers

Instruments Last Change  
Abbott Labor.. 82.22 -0.1% Stock price decreasing
Bristol-Myer.. 47.56 0.5% Stock price increasing
Merck & Comp.. 82.78 0.5% Stock price increasing
Pfizer Inc 42.76 0.6% Stock price increasing
Amgen Inc 176.08 -0.4% Stock price decreasing
Celgene Corp.. 96.51 0.1% Stock price increasing
0,77,28,18,27,22,24,35,34,27
Novartis NAM.. 79.74 0.6% Stock price increasing
Roche Hldg A.. 246.95 0.1% Stock price increasing
Glaxosmithkl.. 1,584.40 0.1% Stock price increasing
Sanofi 75.98 0.0% Stock price unchanged
Biogen Inc 227.67 -1.6% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 June 2019 04:35:26
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB4 - 2019-06-16 05:35:26 - 2019-06-16 04:35:26 - 1000 - Website: OKAY